Europe Sinus Tissue Resection Market Size, Share & Trends Analysis Report By Product (Endoscopes, Ethmoid Forceps, Nasal Scissors, Curetts), By End-use, By Country, And Segment Forecasts, 2022 - 2030

PUBLISHED: July 25, 2022

PAGES: 86 Pages

DELIVERY TIME: 2-10 business days

SELECT AN OPTION

The Europe sinus tissue resection market size is expected to reach USD 263.6 million by 2030, based on a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 6.2% from 2022 to 2030. The rise in the prevalence of chronic sinusitis, rising preference for minimally invasive surgeries, and technological advancements are expected to propel the growth of the industry over the forecast period. Although the market witnessed a significant fall in the sales of sinus tissue resection products, It is expected to recover and flourish over the forecast period. The lockdowns and restrictions resulted in a reduced number of elective surgeries, which further led to a fall in the sales of sinus tissue resection products.

Most countries in Europe specifically observed a major loss of life and financial losses due to the pandemic. Countries like Italy, which had a huge geriatric population, were badly hit by the virus, and recovering from it has been difficult. However, with the European countries now focusing on their healthcare systems more than ever before, the region is trying its best to combat similar situations in the near future. However, with the conduction of mass vaccination programs, the opening of the economies, and economic activities resuming, the market has already started to recover.

Increasing prevalence of chronic sinusitis is among the major factors anticipated to positively contribute to the industry growth. As per the National Institute for Health and Care Excellence, chronic sinusitis is a common condition in Europe, and affects 1 in 10 adults in the U.K. adults. Additionally, according to the European Forum for Research and Foundation in Allergy and Airway Diseases, around 10% of the population is suffering from chronic rhinitis across the European region.

Europe Sinus Tissue Resection Market Report Highlights:

Based on product, the endoscopes segment held the largest revenue share in 2021 owing to its increased usage and higher price range

On the basis of end-use, the hospitals segment held the largest revenue share in 2021 due to the majority of patients opting to undergo surgeries in the hospital setting

Germany held the largest revenue share in 2021 owing to an increase in the prevalence of allergic rhinitis and a well-established healthcare system

The market observed a negative impact due to the pandemic as a result of reduced hospital visits by the patients and restrictions led by the government that led to a fall in the number of elective surgeries

Product Code: GVR-4-68039-960-1

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope
- 1.1.1. Product
- 1.1.2. End-use
- 1.1.3. Country scope
- 1.1.4. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
- 1.3.1. Purchased database
- 1.3.2. GVR's internal database
- 1.3.3. Secondary sources
- 1.3.4. Primary research
- 1.3.5. Details of primary research
  - 1.3.5.1. Data for primary interviews in Europe
1.4. Information or Data Analysis
- 1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
- 1.6.1. Commodity flow analysis (Model 1)
- 1.6.2. Approach 1: Commodity flow approach
- 1.6.3. Volume price analysis (Model 2)
- 1.6.4. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
- 1.9.1. Objective 1
- 1.9.2. Objective 2

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
- 2.2.1. Product outlook
- 2.2.2. End-use outlook
- 2.2.3. Country outlook
2.3. Competitive Insights

Chapter 3. Europe Sinus Tissue Resection Market Variables, Trends & Scope

3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Industry Value Chain Analysis
- 3.3.1. Reimbursement framework
3.4. Market Dynamics
- 3.4.1. Market driver analysis
  - 3.4.1.1. Increasing prevalence of chronic sinusitis
  - 3.4.1.2. Rising preference for minimally invasive surgeries
  - 3.4.1.3. Technological advancements
- 3.4.2. Market restraint analysis
  - 3.4.2.1. Lack of awareness and limited healthcare spending in developing countries
3.5. Europe Sinus Tissue Resection Surgery Market Analysis Tools
- 3.5.1. Industry Analysis - Porter's
  - 3.5.1.1. Supplier power
  - 3.5.1.2. Buyer power
  - 3.5.1.3. Substitution threat
  - 3.5.1.4. Threat of new entrant
  - 3.5.1.5. Competitive rivalry
- 3.5.2. PESTEL Analysis
  - 3.5.2.1. Political landscape
  - 3.5.2.2. Technological landscape
  - 3.5.2.3. Economic landscape
- 3.5.3. Major Deals & Strategic Alliances Analysis
- 3.5.4. Market Entry Strategies

Chapter 4. Europe Sinus Tissue Resection Market: Product Estimates & Trend Analysis

4.1. Definitions and Scope
- 4.1.1. Endoscopes
- 4.1.2. Ethmoid Forceps
- 4.1.3. Nasal Scissors
- 4.1.4. Curetts
- 4.1.5. Others
4.2. Product Market Share, 2021 & 2030
4.3. Segment Dashboard
4.4. Europe Sinus Tissue Resection Market by Product Outlook
4.5. Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the following
- 4.5.1. Endoscopes
  - 4.5.1.1. Market estimates and forecast, 2017 to 2030 (USD Million)
- 4.5.2. Ethmoid Forceps
  - 4.5.2.1. Market estimates and forecast, 2017 to 2030 (USD Million)
- 4.5.3. Nasal Scissors
  - 4.5.3.1. Market estimates and forecast, 2017 to 2030 (USD Million)
- 4.5.4. Curetts
  - 4.5.4.1. Market estimates and forecast, 2017 to 2030 (USD Million)
- 4.5.5. Others
  - 4.5.5.1. Market estimates and forecast, 2017 to 2030 (USD Million)

Chapter 5. Europe Sinus Tissue Resection Market: End-use Estimates & Trend Analysis

5.1. Definitions and Scope
- 5.1.1. Hospitals
- 5.1.2. Ambulatory Surgical Centers
- 5.1.3. Clinics
- 5.1.4. Others
5.2. End-use Market Share, 2021 & 2030
5.3. Segment Dashboard
5.4. Europe Sinus Tissue Resection Market by End-use Outlook
5.5. Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the following
- 5.5.1. Hospitals
  - 5.5.1.1. Market estimates and forecast, 2017 to 2030 (USD Million)
- 5.5.2. Ambulatory Surgical Centers
  - 5.5.2.1. Market estimates and forecast, 2017 to 2030 (USD Million)
- 5.5.3. Clinics
  - 5.5.3.1. Market estimates and forecast, 2017 to 2030 (USD Million)
- 5.5.4. Others
  - 5.5.4.1. Market estimates and forecast, 2017 to 2030 (USD Million)

Chapter 6. Europe Sinus Tissue Resection Market: Country Estimates & Trend Analysis

6.1. Country market share analysis, 2021 & 2030
6.2. Country Market Dashboard
6.3. Europe Country Market Snapshot
6.4. Country Market Share and Leading Players, 2021
- 6.4.1. U.K.
- 6.4.2. Germany
- 6.4.3. France
- 6.4.4. Italy
- 6.4.5. Spain
- 6.4.6. Switzerland
- 6.4.7. Israel
- 6.4.8. Sweden
- 6.4.9. Norway
- 6.4.10. Greece
- 6.4.11. Austria
- 6.4.12. The Netherlands
- 6.4.13. Portugal
- 6.4.14. Luxembourg
- 6.4.15. Denmark
- 6.4.16. Iceland
- 6.4.17. Ireland
- 6.4.18. Belgium
- 6.4.19. Finland
6.5. SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
- 6.5.1. U.K.
- 6.5.2. Germany
- 6.5.3. France
- 6.5.4. Italy
- 6.5.5. Spain
- 6.5.6. Switzerland
- 6.5.7. Israel
- 6.5.8. Sweden
- 6.5.9. Norway
- 6.5.10. Greece
- 6.5.11. Austria
- 6.5.12. The Netherlands
- 6.5.13. Portugal
- 6.5.14. Luxembourg
- 6.5.15. Denmark
- 6.5.16. Iceland
- 6.5.17. Ireland
- 6.5.18. Belgium
- 6.5.19. Finland
6.6. Europe
- 6.6.1. U.K.
  - 6.6.1.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
- 6.6.2. Germany
  - 6.6.2.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
- 6.6.3. France
  - 6.6.3.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
- 6.6.4. Italy
  - 6.6.4.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
- 6.6.5. Spain
  - 6.6.5.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
- 6.6.6. Switzerland
  - 6.6.6.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
- 6.6.7. Israel
  - 6.6.7.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
- 6.6.8. Sweden
  - 6.6.8.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
- 6.6.9. Norway
  - 6.6.9.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
- 6.6.10. Greece
  - 6.6.10.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
- 6.6.11. Brazil
  - 6.6.11.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
- 6.6.12. Austria
  - 6.6.12.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
- 6.6.13. Netherlands
  - 6.6.13.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
- 6.6.14. Portugal
  - 6.6.14.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
- 6.6.15. Luxembourg
  - 6.6.15.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
- 6.6.16. Denmark
  - 6.6.16.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
- 6.6.17. Iceland
  - 6.6.17.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
- 6.6.18. Ireland
  - 6.6.18.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
- 6.6.19. Belgium
  - 6.6.19.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
- 6.6.20. Finland
  - 6.6.20.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)

Chapter 7. Competitive Landscape

7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Company/Competition Categorization
- 7.2.1. Innovators
7.3. Medtronic, plc.
- 7.3.1. List of key distributors and channel partners
- 7.3.2. Key customers
- 7.3.3. Key company market share analysis, 2021
- 7.3.4. Entellus Medical, Inc.
  - 7.3.4.1. Company overview
  - 7.3.4.2. Financial performance
  - 7.3.4.3. Product benchmarking
  - 7.3.4.4. Strategic initiatives
- 7.3.5. Integra Lifesciences
  - 7.3.5.1. Company overview
  - 7.3.5.2. Financial performance
  - 7.3.5.3. Product benchmarking
  - 7.3.5.4. Strategic initiatives
- 7.3.6. B. Braun Melsungen AG
  - 7.3.6.1. Company overview
  - 7.3.6.2. Financial performance
  - 7.3.6.3. Product benchmarking
  - 7.3.6.4. Strategic initiatives
- 7.3.7. Bausch & Lomb Incorporated
  - 7.3.7.1. Company overview
  - 7.3.7.2. Financial performance
  - 7.3.7.3. Product benchmarking
  - 7.3.7.4. Strategic initiatives
- 7.3.8. Karl Storz & Co. Kg
  - 7.3.8.1. Company overview
  - 7.3.8.2. Financial performance
  - 7.3.8.3. Product benchmarking
  - 7.3.8.4. Strategic initiatives

Product Code: GVR-4-68039-960-1

List of Tables

Table 1 List of Abbreviation
Table 2 Europe sinus tissue resection market, by product, 2017 - 2030 (USD Million)
Table 3 Europe sinus tissue resection market, by end-use, 2017 - 2030 (USD Million)
Table 4 Europe sinus tissue resection market, by country, 2017 - 2030 (USD Million)
Table 5 Germany sinus tissue resection market, by product, 2017 - 2030 (USD Million)
Table 6 Germany sinus tissue resection market, by end-use, 2017 - 2030 (USD Million)
Table 7 U.K. sinus tissue resection market, by product, 2017 - 2030 (USD Million)
Table 8 U.K. sinus tissue resection market, by end-use, 2017 - 2030 (USD Million)
Table 9 France sinus tissue resection market, by product, 2017 - 2030 (USD Million)
Table 10 France sinus tissue resection market, by end-use, 2017 - 2030 (USD Million)
Table 11 Italy sinus tissue resection market, by product, 2017 - 2030 (USD Million)
Table 12 Italy sinus tissue resection market, by end-use, 2017 - 2030 (USD Million)
Table 13 Spain sinus tissue resection market, by product, 2017 - 2030 (USD Million)
Table 14 Spain sinus tissue resection market, by end-use, 2017 - 2030 (USD Million)
Table 15 Switzerland sinus tissue resection market, by product, 2017 - 2030 (USD Million)
Table 16 Switzerland sinus tissue resection market, by end-use, 2017 - 2030 (USD Million)
Table 17 Israel sinus tissue resection market, by product, 2017 - 2030 (USD Million)
Table 18 Israel sinus tissue resection market, by end-use, 2017 - 2030 (USD Million)
Table 19 Sweden sinus tissue resection market, by product, 2017 - 2030 (USD Million)
Table 20 Sweden sinus tissue resection market, by end-use, 2017 - 2030 (USD Million)
Table 21 Norway sinus tissue resection market, by product, 2017 - 2030 (USD Million)
Table 22 Norway sinus tissue resection market, by end-use, 2017 - 2030 (USD Million)
Table 23 Greece sinus tissue resection market, by product, 2017 - 2030 (USD Million)
Table 24 Greece sinus tissue resection market, by end-use, 2017 - 2030 (USD Million)
Table 25 Austria sinus tissue resection market, by product, 2017 - 2030 (USD Million)
Table 26 Austria sinus tissue resection market, by end-use, 2017 - 2030 (USD Million)
Table 27 Netherlands sinus tissue resection market, by product, 2017 - 2030 (USD Million)
Table 28 Netherlands sinus tissue resection market, by end-use, 2017 - 2030 (USD Million)
Table 29 Portugal sinus tissue resection market, by product, 2017 - 2030 (USD Million)
Table 30 Portugal sinus tissue resection market, by end-use, 2017 - 2030 (USD Million)
Table 31 Luxembourg sinus tissue resection market, by product, 2017 - 2030 (USD Million)
Table 32 Luxembourg sinus tissue resection market, by end-use, 2017 - 2030 (USD Million)
Table 33 Denmark sinus tissue resection market, by product, 2017 - 2030 (USD Million)
Table 34 Denmark sinus tissue resection market, by end-use, 2017 - 2030 (USD Million)
Table 35 Iceland sinus tissue resection market, by product, 2017 - 2030 (USD Million)
Table 36 Iceland sinus tissue resection market, by end-use, 2017 - 2030 (USD Million)
Table 37 Ireland sinus tissue resection market, by product, 2017 - 2030 (USD Million)
Table 38 Ireland sinus tissue resection market, by end-use, 2017 - 2030 (USD Million)
Table 39 Belgium sinus tissue resection market, by product, 2017 - 2030 (USD Million)
Table 40 Belgium sinus tissue resection market, by end-use, 2017 - 2030 (USD Million)
Table 41 Finland sinus tissue resection market, by product, 2017 - 2030 (USD Million)
Table 42 Finland sinus tissue resection market, by end-use, 2017 - 2030 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in Europe
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Europe Sinus tissue resection :market outlook
Fig. 10 Europe Sinus tissue resection competitive insights
Fig. 11 Parent market outlook
Fig. 12 Related/ancillary market outlook
Fig. 13 Penetration and growth prospect mapping
Fig. 14 Industry value chain analysis
Fig. 15 Europe Sinus tissue resection market driver impact
Fig. 16 Europe Sinus tissue resection market restraint impact
Fig. 17 Europe Sinus tissue resection market strategic initiatives analysis
Fig. 18 Europe Sinus tissue resection market: product movement analysis
Fig. 19 Europe Sinus tissue resection market: product outlook and key takeaway
Fig. 20 Europe Sinus tissue resection market estimates and forecast, 2017 - 2030
Fig. 21 Europe Endoscopes market estimates and forecast, 2017 - 2030
Fig. 22 Europe Ethmoid forceps market estimates and forecast, 2017 - 2030
Fig. 23 Europe Nasal scissors market estimates and forecast, 2017 - 2030
Fig. 24 Europe Currets market estimates and forecast, 2017 - 2030
Fig. 25 Europe Others market estimates and forecast, 2017 - 2030
Fig. 26 Europe Sinus tissue resection market: end-use movement analysis
Fig. 27 Europe Sinus tissue resection market: end-use outlook and key takeaways
Fig. 28 Europe Hospitals market estimates and forecast, 2017 - 2030
Fig. 29 Europe Ambulatory surgical centers market estimates and forecast, 2017 - 2030
Fig. 30 Europe Clinics market estimates and forecast, 2017 - 2030
Fig. 31 Europe Others market estimates and forecast, 2017 - 2030
Fig. 32 Europe sinus tissue resection market: country movement analysis
Fig. 33 Europe sinus tissue resection market: country outlook and key takeaways
Fig. 34 Europe market share and leading players
Fig. 35 Europe SWOT
Fig. 36 Europe, by country
Fig. 37 Europe
Fig. 38 Europe market estimates and forecast, 2017 - 2030
Fig. 39 U.K.
Fig. 40 U.K. market estimates and forecast, 2017 - 2030
Fig. 41 Germany
Fig. 42 Germany market estimates and forecast, 2017 - 2030
Fig. 43 France
Fig. 44 France market estimates and forecast, 2017 - 2030
Fig. 45 Italy
Fig. 46 Italy market estimates and forecast, 2017 - 2030
Fig. 47 Spain
Fig. 48 Spain market estimates and forecast, 2017 - 2030
Fig. 49 Switzerland
Fig. 50 Switzerland market estimates and forecast, 2017 - 2030
Fig. 51 Israel
Fig. 52 Israel market estimates and forecast, 2017 - 2030
Fig. 53 Sweden
Fig. 54 Sweden market estimates and forecast, 2017 - 2030
Fig. 55 Norway
Fig. 56 Norway market estimates and forecast, 2017 - 2030
Fig. 57 Greece
Fig. 58 Greece market estimates and forecast, 2017 - 2030
Fig. 59 Austria
Fig. 60 Austria market estimates and forecast, 2017 - 2030
Fig. 61 Netherlands
Fig. 62 Netherlands market estimates and forecast, 2017 - 2030
Fig. 63 Portugal
Fig. 64 Portugal market estimates and forecast, 2017 - 2030
Fig. 65 Luxembourg
Fig. 66 Luxembourg market estimates and forecast, 2017 - 2030
Fig. 67 Denmark
Fig. 68 Denmark market estimates and forecast, 2017 - 2030
Fig. 69 Iceland
Fig. 70 Iceland market estimates and forecast, 2017 - 2030
Fig. 71 Ireland
Fig. 72 Ireland market estimates and forecast, 2017 - 2030
Fig. 73 Belgium
Fig. 74 Belgium market estimates and forecast, 2017 - 2030
Fig. 75 Finland
Fig. 76 Finland market estimates and forecast, 2017 - 2030